NCT01999530View on ClinicalTrials.gov

The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot Study

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Healthy
Interventions
DRUG

Prazosin Hydrochloride

Gradual upward titration to 15mg/day for approximately three weeks.

Trial Locations (1)

M5T 1R8

Centre for Addiction and Mental Health, Toronto

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Ontario Lung Association

OTHER

collaborator

Pfizer

INDUSTRY

lead

Centre for Addiction and Mental Health

OTHER

NCT01999530 - The Effects of Prazosin on Dopamine in Healthy Humans: A PET Pilot Study | Biotech Hunter | Biotech Hunter